DBS vs Duopa vs Focused Ultrasound for Parkinson's: What's the Difference?

Once Parkinson's medications stop providing smooth, predictable symptom control, families often start hearing about three more advanced options. Deep brain stimulation, Duopa, and focused ultrasound. They are sometimes presented as competing choices, but they are doing different things, and each one fits a different family at a different time.

Here is a plain comparison of all three, what each one actually involves, and when each conversation tends to come up with a movement disorders specialist.

The Three Approaches at a Glance

• Deep brain stimulation (DBS) places electrodes in the brain that deliver continuous electrical pulses, controlled by an implanted battery pack.
• Duopa is a continuous infusion of carbidopa-levodopa gel delivered into the small intestine through a small tube and external pump.
• Focused ultrasound uses MRI-guided sound waves to create a small, targeted lesion in a specific brain region without any incision or implanted device.

Deep Brain Stimulation (DBS)

DBS is a surgically implanted device that delivers small electrical pulses to specific areas of the brain involved in movement. A neurosurgeon places thin electrodes through small openings in the skull, and a battery pack is implanted in the chest, similar to a pacemaker. After surgery, a clinician adjusts the stimulation settings over months to find the combination that best controls symptoms.

It does not cure Parkinson's. It does not stop the underlying disease from progressing. But for the right person it can dramatically reduce tremor, dyskinesia, and OFF time, and it is fully reversible. The device can be turned off or removed at any time, and stimulation settings can be re-tuned as the disease changes.

DBS is FDA approved and has been performed in tens of thousands of people with Parkinson's. Long-term safety data is robust, and Medicare and most private insurance cover it when criteria are met.

Duopa (Carbidopa-Levodopa Enteral Suspension)

Duopa is a continuous infusion of carbidopa-levodopa gel that is delivered directly into the small intestine through a small tube placed by a gastroenterologist. The pump is worn externally during the day and delivers a steady level of medication, smoothing out the peaks and valleys that come with oral pills.

It is intended for people with advanced Parkinson's who experience significant motor fluctuations on oral levodopa. Because the medication bypasses the stomach, absorption is more consistent, which often translates to less OFF time. Duopa does not involve brain surgery, the tube can be removed if the treatment is not working out, and the medication itself is the same levodopa most people are already on.

The trade-off is the daily routine. Setting up and refilling the pump, caring for the tube site, and adjusting to the infusion schedule are real commitments that families need to plan for.

Focused Ultrasound (Incisionless Ablation)

MRI-guided focused ultrasound is a newer option that uses sound waves precisely targeted through the skull to create a small lesion in a specific brain region. There is no incision, no implanted device, and no general anesthesia. The procedure happens inside an MRI scanner so the team can watch in real time and confirm the result.

FDA approval covers one-sided treatment for tremor-dominant Parkinson's, including for the side of the body most affected by tremor. Two-sided treatment is being studied in active trials but is not standard practice yet.

Focused ultrasound is permanent. The lesion cannot be undone, and it is not a fit for everyone, especially people whose symptoms are not primarily tremor or are equally severe on both sides. For the right candidate, it can deliver immediate, lasting tremor reduction without surgery or implants.

A Side by Side Look

• What it is. DBS is an implanted electrical stimulator. Duopa is a continuous medication infusion. Focused ultrasound is a one-time targeted brain lesion.
• Reversibility. DBS is fully reversible. Duopa is reversible by removing the tube. Focused ultrasound is permanent.
• What it treats best. DBS works for tremor, dyskinesia, and OFF time. Duopa specifically targets motor fluctuations. Focused ultrasound is most established for one-sided tremor.
• Brain surgery involved. Yes for DBS. No for Duopa. No incision for focused ultrasound, but it does create a brain lesion.
• Daily routine. DBS is mostly invisible after recovery. Duopa requires pump care and refills every day. Focused ultrasound requires no ongoing maintenance.
• Time horizon. DBS and Duopa take weeks to months of adjustment. Focused ultrasound effects are typically immediate.

Who Each Is For

DBS is most often considered for people with Parkinson's whose symptoms still respond to levodopa but who experience significant motor fluctuations or dyskinesia. Cognitive function and overall health are also factored in, since the surgery and ongoing programming require a person to participate actively in fine-tuning.

Duopa is most often considered for people with advanced Parkinson's who are experiencing severe OFF time on oral medications and either are not candidates for DBS or prefer to avoid brain surgery. It can also be a useful option for people who want to try a less invasive route first.

Focused ultrasound is most often considered for people whose primary disabling symptom is tremor on one side, especially when other treatments have not worked or are not desired. It is a strong option for people who want a one-time procedure without any implanted hardware.

What Trials Are Studying Right Now

Active research is making each of these options better. Adaptive DBS, where the device adjusts stimulation in real time based on brain signals, is being tested in multiple Phase 2 and Phase 3 trials. Newer Duopa-style infusion devices, including subcutaneous options like Vyalev that deliver levodopa continuously under the skin without a tube, are in late-stage trials. Focused ultrasound trials are testing two-sided treatment, new brain targets, and combinations with other therapies.

Browse deep brain stimulation trials, focused ultrasound trials, or continuous infusion trials directly with keyword search.

The Conversation Worth Having

None of these options is the right starting point. They come up after oral medications have stopped providing smooth control, usually years into the disease. The right time to start asking about them is when motor fluctuations, dyskinesia, or persistent tremor are affecting daily life despite a well-managed medication regimen.

A movement disorders specialist is the right person to compare options for a specific case. Bring up all three by name, describe what daily life actually looks like, and ask which one matches the symptoms and goals best. Each of these treatments has trade-offs, and the right answer is rarely obvious without that conversation. Our guide on how to talk to your neurologist about clinical trials walks through how to start.